Search by Drug Name or NDC

    NDC 71610-0594-80 Terazosin Hydrochloride 10 mg/1 Details

    Terazosin Hydrochloride 10 mg/1

    Terazosin Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, LLC. The primary component is TERAZOSIN HYDROCHLORIDE.

    Product Information

    NDC 71610-0594
    Product ID 71610-594_2b26376c-c9c8-4d68-aec5-f3aa773fe7f9
    Associated GPIs 36202040100120
    GCN Sequence Number 022652
    GCN Sequence Number Description terazosin HCl CAPSULE 10 MG ORAL
    HIC3 J7B
    HIC3 Description ALPHA-ADRENERGIC BLOCKING AGENTS
    GCN 47127
    HICL Sequence Number 000094
    HICL Sequence Number Description TERAZOSIN HCL
    Brand/Generic Generic
    Proprietary Name Terazosin Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Terazosin Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name TERAZOSIN HYDROCHLORIDE
    Labeler Name Aphena Pharma Solutions - Tennessee, LLC
    Pharmaceutical Class Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA074823
    Listing Certified Through 2024-12-31

    Package

    NDC 71610-0594-80 (71610059480)

    NDC Package Code 71610-594-80
    Billing NDC 71610059480
    Package 180 CAPSULE in 1 BOTTLE (71610-594-80)
    Marketing Start Date 2021-08-26
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL e5507ea6-bdb3-4363-a68b-0478cbb25f4a Details

    Revised: 8/2021